\-\ Texto\\:\\ \ \(0\)\
\-\ diffuse\\ abdominal\\ tenderness\\,\\ distention\\.\ \(0\)\
\-\ non\\-acute\\ abdomen\\ with\\ no\\ rebound\\.\ \(0\)\
\-\ temp\\:\\ 99\\.1f\ \(0\)\
\-\ wbc\\:\\ 10\\.1\ \(0\)\
\-\ chloride\\ high\\ at\\ 115\ \(0\)\
\-\ potassium\\ low\\ at\\ 3\\.5\ \(0\)\
\-\ metronidazole\\ or\\ vancomycin\\ for\\ 7\\-10\\ days\\.\ \(0\)\
\-\ limited\\ plain\\ film\\ of\\ the\\ upright\\ abdomen\\ shows\\ thickened\\ haustra\\ of\\ the\\ transverse\\ colon\\.\ \(0\)\
\-\ selected\\ axial\\,\\ oral\\ and\\ iv\\ contrast\\ enhanced\\,\\ images\\ show\\ substantially\\ thickened\\ colonic\\ bowel\\ wall\\ with\\ preservation\\ of\\,\\ but\\ thickened\\,\\ haustra\\,\\ comprising\\ the\\ entire\\ colon\\.\\ \\ small\\ bowel\\ is\\ not\\ affected\\.\\ mild\\ pericolonic\\ fat\\ stranding\\ is\\ present\\.\ \(0\)\
\-\ pseudomembranous\\ colitis\ \(3\)\
\-\ inflammatory\\ bowel\\ disease\\ \ \(9\)\
\-\ infectious\\ colitis\\ \\(c\\.\\ difficile\\,\\ yersinia\\,\\ shigella\\,\\ cmv\\)\ \(0\)\
\-\ ischemia\ \(171\)\
\-\ lymphoma\ \(373\)\
\-\ 78yo\\ male\\ presents\\ to\\ ed\\ with\\ a\\ three\\ week\\ history\\ of\\ persistent\\ diarrhea\\ and\\ new\\ onset\\ of\\ diffuse\\ abdominal\\ pain\\ and\\ distension\\.\\ \\ the\\ patient\\ was\\ seen\\ one\\ month\\ ago\\ by\\ his\\ primary\\ care\\ provider\\ and\\ treated\\ for\\ sinusitis\\.\ \(0\)\
\-\ pseudomembranous\\ colitis\\ is\\ a\\ toxin\\ induced\\ inflammatory\\ infection\\ of\\ the\\ colon\\ caused\\ overgrowth\\ of\\ clostridium\\ difficile\\,\\ secondary\\ to\\ antibiotic\\ use\\.\\ \\ historically\\ associated\\ with\\ clindamycin\\,\\ this\\ entity\\ can\\ occur\\ subsequent\\ to\\ almost\\ any\\ antibiotic\\,\\ as\\ well\\ as\\,\\ steroids\\ and\\ chemotherapeutic\\ drugs\\.\\ symptoms\\ begin\\ as\\ early\\ as\\ one\\ day\\ after\\ starting\\ the\\ medication\\ and\\ as\\ late\\ as\\ six\\ weeks\\ after\\ cessation\\.\\ \\ common\\ presentations\\ include\\ low\\ fevers\\,\\ leukocytosis\\,\\ diffuse\\ abdominal\\ pain\\,\\ and\\ of\\ course\\ diarrhea\\.\\ \\ the\\ diarrhea\\ is\\ typically\\ non\\-bloody\\ and\\ should\\ not\\ contain\\ mucous\\.\\ \\ diagnosis\\ is\\ made\\ with\\ fecal\\ testing\\ for\\ toxin\\ by\\ elisa\\ and\\ latex\\ agglutination\\ for\\ c\\.\\ difficile\\.\\ \\ \ \(0\)\
\-\ abnormal\\ plain\\ film\\ findings\\ are\\ seen\\ in\\ 40\\%\\ of\\ patients\\ and\\ include\\ thumbprinting\\,\\ ileus\\,\\ thickened\\ haustra\\,\\ and\\ megacolon\\.\ \(0\)\
\-\ ct\\ findings\\ show\\ a\\ substantially\\ thickened\\ \\(typically\\ \\>15mm\\)\\ colonic\\ wall\\ with\\ preserved\\ haustra\\.\\ findings\\ occur\\ first\\ distally\\ in\\ the\\ rectum\\ and\\ then\\ progress\\ proximally\\.\\ \\ contrast\\ between\\ thickened\\ haustra\\ is\\ described\\ as\\ the\\ accordion\\ sign\\,\\ but\\ is\\ not\\ specific\\.\\ \\ the\\ terminal\\ ileum\\ is\\ typically\\ not\\ affected\\.\\ \\ ascites\\ and\\ pericolonic\\ fat\\ stranding\\ are\\ associated\\ with\\ this\\ disease\\ process\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ haustra\\:\\ 0\\.39506900170000525\ \(0\)\
\-\ thickened\\:\\ 0\\.2706196642835016\ \(0\)\
\-\ difficile\\:\\ 0\\.21127449609829313\ \(0\)\
\-\ colitis\\:\\ 0\\.15863776514956482\ \(0\)\
\-\ diarrhea\\:\\ 0\\.15176352131365337\ \(0\)\
\-\ as\\:\\ 0\\.1503672183696141\ \(0\)\
\-\ substantially\\:\\ 0\\.14503299327214833\ \(0\)\
\-\ and\\:\\ 0\\.1436375395018786\ \(0\)\
\-\ toxin\\:\\ 0\\.13906285975720184\ \(0\)\
\-\ pericolonic\\:\\ 0\\.13454173302121136\ \(0\)\
\-\ pseudomembranous\\:\\ 0\\.13454173302121136\ \(0\)\
\-\ colon\\:\\ 0\\.12214013715745888\ \(0\)\
\-\ is\\:\\ 0\\.1171462611810419\ \(0\)\
\-\ typically\\:\\ 0\\.1126108043872061\ \(0\)\
\-\ the\\:\\ 0\\.10669318952996112\ \(0\)\
\-\ colonic\\:\\ 0\\.10436918899888419\ \(0\)\
\-\ bowel\\:\\ 0\\.10294517583245545\ \(0\)\
\-\ diffuse\\:\\ 0\\.10059802323753833\ \(0\)\
\-\ antibiotic\\:\\ 0\\.10007903753364046\ \(0\)\
\-\ stranding\\:\\ 0\\.09572604874679726\ \(0\)\
\-\ of\\:\\ 0\\.0941756091628043\ \(0\)\
\-\ affected\\:\\ 0\\.08795655275246216\ \(0\)\
\-\ abdominal\\:\\ 0\\.08773344196815284\ \(0\)\
\-\ 78yo\\:\\ 0\\.08551110404392795\ \(0\)\
\-\ agglutination\\:\\ 0\\.08551110404392795\ \(0\)\
\-\ not\\:\\ 0\\.08443565817789059\ \(0\)\
\-\ elisa\\:\\ 0\\.08171042502133405\ \(0\)\
\-\ latex\\:\\ 0\\.08171042502133405\ \(0\)\
\-\ film\\:\\ 0\\.07991406245638648\ \(0\)\
\-\ findings\\:\\ 0\\.07916963343622858\ \(0\)\
\-\ thumbprinting\\:\\ 0\\.07901380034000105\ \(0\)\
\-\ accordion\\:\\ 0\\.07901380034000105\ \(0\)\
\-\ occur\\:\\ 0\\.07864972352289645\ \(0\)\
\-\ chemotherapeutic\\:\\ 0\\.07521312131740715\ \(0\)\
\-\ shigella\\:\\ 0\\.07376817021453258\ \(0\)\
\-\ clostridium\\:\\ 0\\.07376817021453258\ \(0\)\
\-\ historically\\:\\ 0\\.07376817021453258\ \(0\)\
\-\ megacolon\\:\\ 0\\.07376817021453258\ \(0\)\
\-\ with\\:\\ 0\\.07329146149642977\ \(0\)\
\-\ clindamycin\\:\\ 0\\.07251649663607417\ \(0\)\
\-\ inflammatory\\:\\ 0\\.07231270441119865\ \(0\)\
\-\ overgrowth\\:\\ 0\\.07141244229481324\ \(0\)\
\-\ 15mm\\:\\ 0\\.07141244229481324\ \(0\)\
\-\ plain\\:\\ 0\\.0705567525348166\ \(0\)\
\-\ yersinia\\:\\ 0\\.07042483203276437\ \(0\)\
\-\ comprising\\:\\ 0\\.06953142987860092\ \(0\)\
\-\ metronidazole\\:\\ 0\\.06796552706101854\ \(0\)\
\-\ presentations\\:\\ 0\\.06796552706101854\ \(0\)\
\-\ show\\:\\ 0\\.06788871393223964\ \(0\)\
\-\ chloride\\:\\ 0\\.06727086651060568\ \(0\)\
\-\ fat\\:\\ 0\\.0665240045045557\ \(0\)\
\-\ abdomen\\:\\ 0\\.06525193378736818\ \(0\)\
\-\ wall\\:\\ 0\\.06505354827826718\ \(0\)\
\-\ potassium\\:\\ 0\\.06491513859088634\ \(0\)\
\-\ fecal\\:\\ 0\\.06491513859088634\ \(0\)\
\-\ for\\:\\ 0\\.06482609429621036\ \(0\)\
\-\ vancomycin\\:\\ 0\\.06392752832883747\ \(0\)\
\-\ include\\:\\ 0\\.06362902105316884\ \(0\)\
\-\ 115\\:\\ 0\\.06347018748801177\ \(0\)\
\-\ begin\\:\\ 0\\.061835863725527684\ \(0\)\
\-\ low\\:\\ 0\\.061363420967006206\ \(0\)\
\-\ one\\:\\ 0\\.061228838510602415\ \(0\)\
\-\ proximally\\:\\ 0\\.060444629834606\ \(0\)\
\-\ starting\\:\\ 0\\.06012684930624356\ \(0\)\
\-\ cmv\\:\\ 0\\.059819489710397244\ \(0\)\
\-\ upright\\:\\ 0\\.05952188922822037\ \(0\)\
\-\ cessation\\:\\ 0\\.05952188922822037\ \(0\)\
\-\ preservation\\:\\ 0\\.05841783488695945\ \(0\)\
\-\ provider\\:\\ 0\\.05841783488695945\ \(0\)\
\-\ leukocytosis\\:\\ 0\\.05841783488695945\ \(0\)\
\-\ entity\\:\\ 0\\.058161007099919435\ \(0\)\
\-\ ileus\\:\\ 0\\.058161007099919435\ \(0\)\
\-\ selected\\:\\ 0\\.05743022462491058\ \(0\)\
\-\ associated\\:\\ 0\\.056366014788136624\ \(0\)\
\-\ preserved\\:\\ 0\\.05612014819189593\ \(0\)\
\-\ distally\\:\\ 0\\.05612014819189593\ \(0\)\
\-\ distension\\:\\ 0\\.0555279326812103\ \(0\)\
\-\ sinusitis\\:\\ 0\\.055152937563214655\ \(0\)\
\-\ mucous\\:\\ 0\\.055152937563214655\ \(0\)\
\-\ ascites\\:\\ 0\\.055152937563214655\ \(0\)\
\-\ terminal\\:\\ 0\\.05497091965316474\ \(0\)\
\-\ progress\\:\\ 0\\.05444515786743734\ \(0\)\
\-\ ileum\\:\\ 0\\.05411034985422407\ \(0\)\
\-\ rectum\\:\\ 0\\.0539473261306791\ \(0\)\
\-\ drugs\\:\\ 0\\.05347460607748997\ \(0\)\
\-\ contain\\:\\ 0\\.05347460607748997\ \(0\)\
\-\ temp\\:\\ 0\\.05302458552429347\ \(0\)\
\-\ induced\\:\\ 0\\.05302458552429347\ \(0\)\
\-\ but\\:\\ 0\\.05288257446871105\ \(0\)\
\-\ contrast\\:\\ 0\\.05196052985353607\ \(0\)\
\-\ distention\\:\\ 0\\.05192053118303255\ \(0\)\
\-\ after\\:\\ 0\\.0518789134613923\ \(0\)\
\-\ rebound\\:\\ 0\\.05093292092098368\ \(0\)\
\-\ late\\:\\ 0\\.05047558008015798\ \(0\)\
\-\ seen\\:\\ 0\\.050347035805403\ \(0\)\
\-\ medication\\:\\ 0\\.04942125332413179\ \(0\)\
\-\ entire\\:\\ 0\\.04865563385928776\ \(0\)\
\-\ almost\\:\\ 0\\.04803345866562176\ \(0\)\
\-\ six\\:\\ 0\\.04803345866562176\ \(0\)\
\-\ testing\\:\\ 0\\.04803345866562176\ \(0\)\
\-\ fevers\\:\\ 0\\.047210682756413186\ \(0\)\
\-\ steroids\\:\\ 0\\.046977302373563075\ \(0\)\
\-\ ischemia\\:\\ 0\\.04631012242868094\ \(0\)\
\-\ by\\:\\ 0\\.045413422055055566\ \(0\)\
\-\ disease\\:\\ 0\\.044890103027254644\ \(0\)\
\-\ described\\:\\ 0\\.04338378377872924\ \(0\)\
\-\ infectious\\:\\ 0\\.04302420327994954\ \(0\)\
\-\ caused\\:\\ 0\\.04287422203497016\ \(0\)\
\-\ oral\\:\\ 0\\.042824756865654394\ \(0\)\
\-\ ed\\:\\ 0\\.04277555135721573\ \(0\)\
\-\ limited\\:\\ 0\\.042677908517707114\ \(0\)\
\-\ made\\:\\ 0\\.04123989827248608\ \(0\)\
\-\ transverse\\:\\ 0\\.04119833000998346\ \(0\)\
\-\ persistent\\:\\ 0\\.04119833000998346\ \(0\)\
\-\ use\\:\\ 0\\.040912401981822014\ \(0\)\
\-\ enhanced\\:\\ 0\\.040713379052486294\ \(0\)\
\-\ are\\:\\ 0\\.040579309433506926\ \(0\)\
\-\ specific\\:\\ 0\\.04051849411525083\ \(0\)\
\-\ subsequent\\:\\ 0\\.040479998669636176\ \(0\)\
\-\ at\\:\\ 0\\.04039303282692189\ \(0\)\
\-\ process\\:\\ 0\\.04010349714298597\ \(0\)\
\-\ to\\:\\ 0\\.04010262273796497\ \(0\)\
\-\ course\\:\\ 0\\.039496230845777115\ \(0\)\
\-\ 40\\:\\ 0\\.03932486176144823\ \(0\)\
\-\ ago\\:\\ 0\\.03912327059761099\ \(0\)\
\-\ early\\:\\ 0\\.03854327359115308\ \(0\)\
\-\ pain\\:\\ 0\\.03826748532826568\ \(0\)\
\-\ iv\\:\\ 0\\.03820572515171571\ \(0\)\
\-\ care\\:\\ 0\\.03820572515171571\ \(0\)\
\-\ then\\:\\ 0\\.03785084512262549\ \(0\)\
\-\ wbc\\:\\ 0\\.037792983038691365\ \(0\)\
\-\ sign\\:\\ 0\\.03701831948912444\ \(0\)\
\-\ new\\:\\ 0\\.03699180284390864\ \(0\)\
\-\ this\\:\\ 0\\.03674691102620551\ \(0\)\
\-\ first\\:\\ 0\\.03608396861940725\ \(0\)\
\-\ week\\:\\ 0\\.035964557732817114\ \(0\)\
\-\ three\\:\\ 0\\.03589363461137037\ \(0\)\
\-\ should\\:\\ 0\\.03488955255022165\ \(0\)\
\-\ between\\:\\ 0\\.03474259456855918\ \(0\)\
\-\ any\\:\\ 0\\.03455697211017305\ \(0\)\
\-\ onset\\:\\ 0\\.034334981312968214\ \(0\)\
\-\ day\\:\\ 0\\.034059844601493194\ \(0\)\
\-\ days\\:\\ 0\\.033849192414395726\ \(0\)\
\-\ tenderness\\:\\ 0\\.03353267441251278\ \(0\)\
\-\ treated\\:\\ 0\\.033297643465684604\ \(0\)\
\-\ primary\\:\\ 0\\.03287864062444836\ \(0\)\
\-\ month\\:\\ 0\\.03252677413913359\ \(0\)\
\-\ his\\:\\ 0\\.032428620071251864\ \(0\)\
\-\ infection\\:\\ 0\\.03229932660300536\ \(0\)\
\-\ abnormal\\:\\ 0\\.032124410745249604\ \(0\)\
\-\ weeks\\:\\ 0\\.03204596988722619\ \(0\)\
\-\ lymphoma\\:\\ 0\\.0318450435432646\ \(0\)\
\-\ secondary\\:\\ 0\\.03169336340787137\ \(0\)\
\-\ shows\\:\\ 0\\.03138260695464675\ \(0\)\
\-\ axial\\:\\ 0\\.03088653205939546\ \(0\)\
\-\ high\\:\\ 0\\.030389176370875456\ \(0\)\
\-\ common\\:\\ 0\\.030323945572955903\ \(0\)\
\-\ mild\\:\\ 0\\.030310953709707995\ \(0\)\
\-\ patients\\:\\ 0\\.030080127680902062\ \(0\)\
\-\ symptoms\\:\\ 0\\.02925607450766233\ \(0\)\
\-\ can\\:\\ 0\\.028059668406246154\ \(0\)\
\-\ diagnosis\\:\\ 0\\.027718771644632496\ \(0\)\
\-\ small\\:\\ 0\\.027581927932052844\ \(0\)\
\-\ present\\:\\ 0\\.027437493212580155\ \(0\)\
\-\ in\\:\\ 0\\.026603491807936062\ \(0\)\
\-\ well\\:\\ 0\\.025890720254357326\ \(0\)\
\-\ presents\\:\\ 0\\.025722110839360365\ \(0\)\
\-\ images\\:\\ 0\\.024733704887159258\ \(0\)\
\-\ male\\:\\ 0\\.023807160820452495\ \(0\)\
\-\ history\\:\\ 0\\.02042885845481647\ \(0\)\
\-\ ct\\:\\ 0\\.020356753269783704\ \(0\)\
\-\ was\\:\\ 0\\.018635027830870798\ \(0\)\
\-\ or\\:\\ 0\\.01860146397941626\ \(0\)\
\-\ patient\\:\\ 0\\.01739129661953135\ \(0\)\
\-\ no\\:\\ 0\\.01738802541802099\ \(0\)\
